SUMMARY: The 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2010) -- the American Society for Microbiology's annual meeting focused on infectious diseases including HIV -- is taking place this week, September 12-15, in Boston. At the same time, the 1st annual United States Conference on AIDS (USCA 2010), sponsored by the National Minority AIDS Council, is underway in Orlando, with an emphasis on community-based response to the AIDS epidemic.

Over the next few weeks, HIVandHepatitis.com will provide reports on selected highlights from conference presentations.

ICAAC will include oral and poster presentations on HIV pathogenesis, experimental HIV therapies -- including 48-week data from a study of Gilead Science's new Quad pill -- complications of HIV and its treatment, and HIV/HCV coinfection.

The full ICAAC 2010 conference program and abstracts are now available online at www.icaac.org, with additional materials to be added as presentations occur.

The mission of new United States Conference on AIDS is to "increase the strength and diversity of the community-based response to the AIDS epidemic through education, training, new partnerships, collaboration and networking." The meeting will bring together more than 3000 people working in the HIV field, including medical professionals, case managers, public health experts, policymakers, advocates, and people with HIV themselves.

Further information about and materials from USCA are available online at http://www.nmac.org/index/2010-united-states-conference-on-aids. The Center for Disease Control and Prevention's National Prevention Information Network will be live tweeting from USCA @CDCNPIN.

9/14/10

Sources

Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2010). http://www.icaac.org.

National Minority AIDS Council. Welcome Letter from Paul A. Kawata, Executive Director of NMAC.

United States Conference on AIDS (USCA 2010).